NEW YORK, Feb. 19, 2016 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in United States District Court for the District of Utah against Skullcandy, Inc. (NASDAQ:SKUL) (the “Company”) on behalf those individuals and/or entities that purchased securities from August 7, 2015 and January 11, 2016, inclusive (the “Class Period”).
Shareholders who incurred losses on Skullcandy, Inc. securities purchased within the class period are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.
If you purchased shares of Skullcandy, Inc. within the period August 7, 2015 and January 11, 2016, inclusive, you may, no later than April 12, 2016, request that the Court appoint you lead plaintiff of the proposed class.
Throughout the Class Period defendants issued materially false and misleading statements to investors and failed to disclose that: (1) Skullcandy’s revenue and net income guidance for the third quarter and full year 2015 were unattainable; (2) Skullcandy’s revenue and net income guidance for the fourth quarter and full year 2015 were unattainable; (3) Skullcandy faced challenges with its largest Chinese distributor; (4) defendant Rick Alden and Ptarmagin, an entity controlled by Alden, engaged in insider selling and realized proceeds in excess of $4 million with knowledge of undisclosed materially adverse facts; and (5) as a result, defendants’ statements about Skullcandy’s business, operations, and prospects were false and misleading and lacked a reasonable basis.
On January 11, 2016, Skullcandy issued a press release updating the company’s financial outlook for the fourth quarter of 2015 and announced that the company had missed its quarterly net sales projections. Following this news, Skullcandy stock fell $1.29, more than 28%, to close at $3.26 per share on January 12, 2016.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com. All e-mail correspondence should make reference to the “Skullcandy Investigation.”
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
Contact: Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq. Gregory Stone, Director of Case and Financial Analysis Email: [email protected], [email protected] or [email protected] Tel: (800) 575-0735 or (212) 545-4774


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 



